Online citations, reference lists, and bibliographies.
← Back to Search

Localization And Effects Of Neuropeptide Y, Vasoactive Intestinal Polypeptide, Substance P, And Calcitonin Gene–related Peptide In Human Temporal Arteries

I. Jansen, R. Uddman, M. Hocherman, Rolf Ekman, K. Jensen, J. Olesen, Pia Srienholm, L. Edvinsson
Published 1986 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Nerve fibers containing neuropeptide Y (NPY), vasoactive intestinal polypeptide (VIP), substance P (SP), and calcitonin gene–related peptide (CGRP) were seen in the adventitia or at the adventitia–media border of the human temporal artery. Pharmacological experiments on isolated temporal artery segments revealed that NPY potentiated the vasoconstrictor responses to noradrenaline, but had no vasoconstrictor ability or only a small vasoconstrictor ability per se. VIP, peptide histidine methionine 27 (PHM‐27), SP, neurokinin A (NKA), and CGRP potently relaxed vessels precontracted by prostaglandin F2α, the relative potency being CGRP > SP > NKA  VIP  PHM‐27. The amount of relaxation varied between 67 and 91% of the prostaglandin F2α–induced contraction. The peptide effects were not antagonized by classic adrenergic or cholinergic blockers, suggesting interactions via separate receptor sites.
This paper references
10.1016/0304-3940(85)90296-4
Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: Trigeminal origin and co-existence with substance P
R. Uddman (1985)
10.1038/306032A0
Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor
H. Nawa (1983)
10.1111/J.1748-1716.1981.TB06876.X
Evidence that substance P is a mediator of antidromic vasodilatation using somatostatin as a release inhibitor.
B. Gazelius (1981)
10.1111/J.1748-1716.1982.TB07159.X
Antagonism by (D-Pro2, D-Trp7,9)-substance P of the cerebrovascular dilatation induced by substance P.
L. Edvinsson (1982)
10.1016/0166-2236(85)90050-5
Functional role of perivascular peptides in the control of cerebral circulation
L. Edvinsson (1985)
10.1016/0006-8993(85)90027-7
Coexistence of calcitonin gene-related peptide and substance P-like peptide in single cells of the trigeminal ganglion of the rat: immunohistochemical analysis
Y. Lee (1985)
10.1016/0167-0115(84)90064-8
Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers
E. Ekblad (1984)
10.1016/0167-0115(85)90019-9
Neuropeptide Y-like immunoreactivity in perivascular nerve fibres of the guinea-pig
R. Uddman (1985)
10.1113/jphysiol.1982.sp014142
Feline cerebral veins and arteries: comparison of autonomic innervation and vasomotor responses
L. Edvinsson (1982)
Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action.
C. Wahlestedt (1985)
10.1111/J.1748-1716.1981.TB06717.X
Tissue concentration and release of substance P-like immunoreactivity in the dental pulp.
E. Brodin (1981)
10.1111/J.1748-1716.1946.TB00335.X
Choline Esterases in some Marine Invertebrates
K. Augustinsson (1946)
10.1210/ENDO-119-5-2313
Calcitonin gene-related peptide in thyroid nerve fibers and C cells: effects on thyroid hormone secretion and response to hypercalcemia.
T. Grunditz (1986)
10.1084/JEM.102.1.49
STUDIES ON ANTIBODY PRODUCTION I. A METHOD FOR THE HISTOCHEMICAL DEMONSTRATION OF SPECIFIC ANTIBODY AND ITS APPLICATION TO A STUDY OF THE HYPERIMMUNE RABBIT
A. H. Coons (1955)
10.1016/0166-2236(85)90112-2
Migraine and regional cerebral blood flow
J. Olesen (1985)
10.1038/304547A0
Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27
N. Itoh (1983)
10.1126/SCIENCE.6719122
Vasoactive intestinal polypeptide-like substance: the potential transmitter for cerebral vasodilation.
T. J. Lee (1984)
10.7326/0003-4819-32-2-350_1
Headache and other head pain
H. Wolff (1972)



This paper is referenced by
10.1056/NEJMOA030505
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.
J. Olesen (2004)
10.1046/j.1468-1331.1998.540329.x
Neuropeptides in headache
L. Edvinsson (1998)
10.1016/0306-4522(91)90253-K
Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells
V. Dimtriadou (1991)
10.1007/s00210-005-1064-4
BIBN4096BS and CGRP8-37 antagonize the relaxant effects of α-CGRP more than those of β-CGRP in human extracranial arteries
R. Verheggen (2005)
10.1523/JNEUROSCI.07-12-04129.1987
Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain
S. Markowitz (1987)
10.1007/978-1-4612-0303-2_4
Neuropeptides in Human Cerebral Arteries
L. Edvinsson (1994)
10.1007/BF01827433
Sweating and vascular responses in the face: Normal regulation and dysfunction in migraine, cluster headache and harlequin syndrome
P. Drummond (2005)
10.1007/s10072-019-03786-7
Anti-CGRP in cluster headache therapy
L. Giani (2019)
10.1016/0196-9781(89)90181-2
Evidence that vascular actions of PHI are mediated by a VIP-preferring receptor
M. Huang (1989)
10.1007/978-3-030-14121-9_1
Trigeminal Mechanisms of Nociception
A. Andreou (2020)
10.1111/head.13858
Calcitonin Gene‐Related Peptide Receptor Antagonists (Gepants) for the Acute Treatment of Nausea in Episodic Migraine: A Systematic Review and Meta‐Analysis
T. L. H. Chan (2020)
10.1016/j.semarthrit.2009.03.002
Nerve growth factor in rheumatic diseases.
M. Seidel (2010)
10.1111/j.1526-4610.1991.hed3102091.x
On Pain Mechanisms in Cluster Headache
J. E. Hardebo (1991)
10.1007/s00415-010-5582-8
Painful scalp arteries in migraine
C. Cianchetti (2010)
10.1016/0306-3623(88)90002-X
The sensory-efferent function of capsaicin-sensitive sensory neurons.
C. Maggi (1988)
10.1111/j.1468-2982.2008.01675.x
The Blood-Brain Barrier in Migraine Treatment
L. Edvinsson (2008)
10.1517/13543784.2012.681044
CGRP receptor antagonists: an expanding drug class for acute migraine?
A. Negro (2012)
10.1016/0163-7258(88)90028-9
Neuropeptide Y as an autonomic neurotransmitter.
E. Potter (1988)
10.1046/j.1468-2982.1988.0802083.x
Neurogenically Mediated Plasma Extravasation in Dura Mater: Effect of Ergot Alkaloids: A Possible Mechanism of Action in Vascular Headache
S. Markowitz (1988)
10.3171/JNS.1992.77.3.0417
Neuropeptide Y in the primate model of subarachnoid hemorrhage.
R. Pluta (1992)
10.1136/jnnp.66.3.390
Decreased CGRP, but preserved Trk A immunoreactivity in nerve fibres in inflamed human superficial temporal arteries
G. Saldanha (1999)
10.1016/0196-9781(89)90169-1
Effect of neurokinin A on human temporal muscle blood flow
C. Tuxen (1989)
10.1161/01.STR.29.1.212
Weakness of sympathetic neural control of human pial compared with superficial temporal arteries reflects low innervation density and poor sympathetic responsiveness.
R. Bevan (1998)
10.1111/j.1468-2982.2003.00719.x
Blockade of CGRP Receptors in the Intracranial Vasculature: A New Target in the Treatment of Headache
L. Edvinsson (2004)
10.1016/0304-3959(86)90162-4
Peptide-containing nerve fibres in human extracranial tissue: a morphological basis for neuropeptide involvement in extracranial pain?
R. Uddman (1986)
10.1007/BF00319418
Ganglion cells immunoreactive for catecholamine-synthesizing enzymes, neuropeptide Y and vasoactive intestinal polypeptide in the rat adrenal gland
Y. Oomori (2004)
10.1111/j.1742-1241.2009.02294.x
Capsaicin jelly against migraine pain
C. Cianchetti (2010)
10.1016/0143-4179(92)90155-P
Substance P augments the rate of vasodilation induced by calcitonin gene-related peptide in porcine ophthalmic artery in vitro
M. Vincent (1992)
10.25911/5d6905547996b
Mechanisms of peripheral nervous control of rat iris arterioles
D. Gould (1996)
10.1007/BF00225604
Axonal tracing of autonomic nerve fibers to the superficial temporal artery in the rat
R. Uddman (2004)
10.1046/j.1468-2982.1991.1104175.x
Pain, Tenderness, Wheal and Flare Induced by Substance-P, Bradykinin and 5-Hydroxytryptamine in Humans
K. Jensen (1991)
10.1046/j.1468-2982.1995.1504272.x
Neuropeptides in the Cerebral Circulation: Relevance to Headache
L. Edvinsson (1995)
See more
Semantic Scholar Logo Some data provided by SemanticScholar